Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Colorectal

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Tumour response rate · people with metastatic colorectal cancer ‐ extended RAS WT

The intervention probably leads to higher tumour response rate (moderate certainty).

1 finding from 1 review

Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
OR 4.28 [2.61, 7.03]
4 studies · 1001 participants
Moderate

Tumour response rate · people with metastatic colorectal cancer ‐ extended RAS MT

The intervention showed no clear difference in tumour response rate (moderate certainty).

1 finding from 1 review

Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
OR 0.76 [0.55, 1.05]
3 studies · 840 participants
Moderate